U.S. Food and Drug Administration (FDA) (2021, April 23). FDA and CDC Lift Recommended Pause on Johnson & Johnson (Janssen) COVID-19 Vaccine Use Following thorough Safety Review.
https://www.fda.gov/news-events/press-announcements/fda-and-cdc-lift-recommended-pause-johnson-johnson-janssen-covid-19-vaccine-use-following-thorough

has been cited by the following article:

• TITLE: CDC Policy Changes during the COVID-19 Pandemic

  AUTHORS: Saitejaswi Kanuri, Allison Chen, Daniel J. Barnett, Edbert B. Hsu

  KEYWORDS: COVID-19, CDC COVID-19 Guidance, COVID-19 Policy, Disaster Preparedness

  JOURNAL NAME: Open Journal of Social Sciences, Vol.12 No.6, June 19, 2024

  ABSTRACT: Throughout the COVID-19 pandemic, the U.S. Centers for Disease Control and Prevention (CDC) provided guidance to the nation’s public, often in the face of extremely challenging and novel circumstances. We review the CDC’s COVID-19 policies and the subsequent public response pertaining to masks, social gatherings, travel, return to work/school, quarantine, and vaccinations, between January 2020 and April 2023. Rapidly changing conditions as well as evolving science and information necessitated frequent updates to CDC guidance, however, the decision-making processes, implementation, and communication regarding changes in policy have drawn criticism. Identifying areas for improvement and implementing strategies to address these concerns will be of importance to better prepare the nation for issuing and communicating public health guidance during future pandemics.